RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 108 filers reported holding RIGEL PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 4.71 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $44,000 | +4.8% | 37,550 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $42,000 | -90.2% | 37,550 | -73.8% | 0.00% | -89.3% |
Q1 2022 | $429,000 | +725.0% | 143,592 | +845.3% | 0.03% | +64.7% |
Q1 2021 | $52,000 | -69.8% | 15,190 | -79.0% | 0.02% | -65.3% |
Q4 2016 | $172,000 | -86.0% | 72,249 | -78.3% | 0.05% | -86.2% |
Q3 2016 | $1,225,000 | +121.9% | 333,657 | +34.9% | 0.35% | +58.0% |
Q2 2016 | $552,000 | +101.5% | 247,340 | +87.5% | 0.22% | +117.5% |
Q1 2016 | $274,000 | +64.1% | 131,889 | +140.0% | 0.10% | +32.1% |
Q4 2015 | $167,000 | +22.8% | 54,960 | 0.0% | 0.08% | +4.0% |
Q3 2015 | $136,000 | -22.7% | 54,960 | 0.0% | 0.08% | -22.7% |
Q2 2015 | $176,000 | -10.2% | 54,960 | 0.0% | 0.10% | -11.0% |
Q1 2015 | $196,000 | +553.3% | 54,960 | +318.9% | 0.11% | +505.6% |
Q4 2014 | $30,000 | +20.0% | 13,120 | 0.0% | 0.02% | -5.3% |
Q3 2014 | $25,000 | -47.9% | 13,120 | 0.0% | 0.02% | -38.7% |
Q2 2014 | $48,000 | – | 13,120 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CM Management, LLC | 1,500,000 | $1,620,000 | 1.72% |
Soleus Capital Management, L.P. | 14,803,015 | $15,987,256 | 1.48% |
ARMISTICE CAPITAL, LLC | 17,136,000 | $18,506,880 | 0.28% |
SPHERA FUNDS MANAGEMENT LTD. | 1,228,126 | $1,326,376 | 0.24% |
GSA CAPITAL PARTNERS LLP | 971,441 | $1,049 | 0.09% |
NJ State Employees Deferred Compensation Plan | 200,000 | $216,000 | 0.03% |
Providence Wealth Advisors, LLC | 27,500 | $29,013 | 0.03% |
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 1,151,765 | $1,243,906 | 0.03% |
XTX Topco Ltd | 164,238 | $177,377 | 0.03% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 3,369,076 | $3,638,602 | 0.02% |